Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes

  • Deepak L. Bhatt
    From the Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio (D.L.B., E.J.T.); and the Harvard Clinical Research Institute, Division of Cardiology, Beth Israel Deaconess Medical Center, Division of Cardiology, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass (D.E.C., R.E.K.).
  • Eric J. Topol
    From the Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio (D.L.B., E.J.T.); and the Harvard Clinical Research Institute, Division of Cardiology, Beth Israel Deaconess Medical Center, Division of Cardiology, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass (D.E.C., R.E.K.).

収録刊行物

  • Circulation

    Circulation 112 (6), 906-922, 2005-08-09

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ